Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Hepatitis B"" wg kryterium: Temat


Tytuł :
Real-world prevalence of hepatitis B virus reactivation in cancer patients in Taiwan.
Autorzy :
Chen CH; Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan.
Hsieh HH; Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan.
Wu TY; Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan.; Department of Pharmacology, School of Medicine, Tzu Chi University, Hualien, Taiwan.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Jan; Vol. 27 (1), pp. 63-70. Date of Electronic Publication: 2020 Apr 07.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B virus*
Hepatitis B/*complications
Hepatitis B/*epidemiology
Neoplasms/*complications
Neoplasms/*epidemiology
Virus Activation/*drug effects
Adult ; Aged ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Antiviral Agents/therapeutic use ; Female ; Hepatitis B/virology ; Hepatitis B Surface Antigens/analysis ; Humans ; Incidence ; Male ; Mass Screening ; Middle Aged ; Prevalence ; Retrospective Studies ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
[A 2020 update on the progress of treatment and new drug clinical trials for hepatitis B].
Autorzy :
Jia JD; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing 100050, China.
Niu JQ; Department of Hepatology & Phase I Clinical Research Center, The First Hospital of Jilin University, Changchun 130021, China.
You H; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing 100050, China.
Kong YY; Clinical Epidemiology & EBM Unit, National Clinical Research Center for Digestive Diseases; Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Hou JL; Clinical Epidemiology & EBM Unit, National Clinical Research Center for Digestive Diseases; Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Pokaż więcej
Źródło :
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 Feb 20; Vol. 29 (2), pp. 97-101.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B*/drug therapy
Hepatitis B, Chronic*/drug therapy
Pharmaceutical Preparations*
Antiviral Agents/therapeutic use ; DNA, Viral ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans
Czasopismo naukowe
Tytuł :
Screening for Hepatitis B in Nonpregnant Adolescents and Adults.
Autorzy :
Jin J; Associate Editor, JAMA.
Pokaż więcej
Źródło :
JAMA [JAMA] 2020 Dec 15; Vol. 324 (23), pp. 2452.
Typ publikacji :
Patient Education Handout
MeSH Terms :
Hepatitis B virus*/immunology
Hepatitis B Surface Antigens/*blood
Hepatitis B, Chronic/*diagnosis
Mass Screening/*standards
Adolescent ; Adult ; Hepatitis B Vaccines ; Humans ; Mass Screening/adverse effects ; Risk Factors
Tytuł :
Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
Autorzy :
Krist AH; Fairfax Family Practice Residency, Fairfax, Virginia.; Virginia Commonwealth University, Richmond.
Davidson KW; Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York.
Mangione CM; University of California, Los Angeles.
Barry MJ; Harvard Medical School, Boston, Massachusetts.
Cabana M; University of California, San Francisco.
Caughey AB; Oregon Health & Science University, Portland.
Donahue K; University of North Carolina at Chapel Hill.
Doubeni CA; Mayo Clinic, Rochester, Minnesota.
Epling JW Jr; Virginia Tech Carilion School of Medicine, Roanoke.
Kubik M; George Mason University, Fairfax, Virginia.
Ogedegbe G; New York University, New York, New York.
Owens DK; Stanford University, Stanford, California.
Pbert L; University of Massachusetts Medical School, Worcester.
Silverstein M; Boston University, Boston, Massachusetts.
Simon MA; Northwestern University, Evanston, Illinois.
Tseng CW; University of Hawaii, Honolulu.; Pacific Health Research and Education Institute, Honolulu, Hawaii.
Wong JB; Tufts University School of Medicine, Boston, Massachusetts.
Pokaż więcej
Corporate Authors :
US Preventive Services Task Force
Źródło :
JAMA [JAMA] 2020 Dec 15; Vol. 324 (23), pp. 2415-2422.
Typ publikacji :
Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B virus*/immunology
Hepatitis B Surface Antigens/*blood
Hepatitis B, Chronic/*diagnosis
Mass Screening/*standards
Adolescent ; Adult ; Emigrants and Immigrants ; Hepatitis B Vaccines ; Humans ; Mass Screening/adverse effects ; Risk Factors ; United States
Czasopismo naukowe
Tytuł :
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis.
Autorzy :
Brunetto MR; Pisa, Italy.
Carey I; London, UK.
Maasoumy B; Hannover, Germany.
Marcos-Fosch C; Barcelona, Spain.
Boonstra A; Rotterdam, the Netherlands.
Caviglia GP; Turin, Italy.
Loglio A; Milan, Italy.
Cavallone D; Pisa, Italy.
Scholtes C; Lyon, France.
Ricco G; Pisa, Italy.
Smedile A; Turin, Italy.
Riveiro-Barciela M; Barcelona, Spain.
van Bömmel F; Leipzig, Germany.
van der Eijk A; Rotterdam, the Netherlands.
Zoulim F; Lyon, France.
Berg T; Leipzig, Germany.
Cornberg M; Hannover, Germany.
Lampertico P; Milan, Italy.
Agarwal K; London, UK.
Buti M; Barcelona, Spain.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Mar; Vol. 53 (6), pp. 733-744. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B e Antigens*
Hepatitis B, Chronic*/diagnosis
Adult ; DNA, Viral/genetics ; Female ; Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Humans ; Male ; Prospective Studies ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Method for detecting hepatitis B virus in blood plasma at low viral load using real-time PCR.
Autorzy :
Serikova EN; Saint-Petersburg Pasteur Institute.
Semenov AV; Saint-Petersburg Pasteur Institute.; Saint-Petersburg State Medical University n.a. acad. I.P. Pavlov.; North-West State Medical University n.a. I.I. Mechnikov.
Ostankova YV; Saint-Petersburg Pasteur Institute.
Totolian AA; Saint-Petersburg Pasteur Institute.; Saint-Petersburg State Medical University n.a. acad. I.P. Pavlov.
Pokaż więcej
Transliterated Title :
Метод выявления вируса гепатита B в плазме крови при низкой вирусной нагрузке с использованием ПЦР в режиме реального времени.
Źródło :
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2021 Feb 10; Vol. 66 (1), pp. 59-64.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B*/diagnosis
Hepatitis B*/epidemiology
Hepatitis B virus*/genetics
Blood Donors ; DNA, Viral/genetics ; Female ; Hepatitis B Surface Antigens/genetics ; Humans ; Plasma ; Pregnancy ; Real-Time Polymerase Chain Reaction ; Russia ; Viral Load
Czasopismo naukowe
Tytuł :
Usefulness of quantitative hepatitis B surface antigen testing in hepatitis B community-based screening.
Autorzy :
Chang KC; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Lee CY; Department of Laboratory Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Chang TS; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Yunlin, Taiwan; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Hung CH; Department of Internal Medicine, Division of Hepato-Gastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan.
Chen WM; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Chen MY; College of Nursing, Chang Gung University of Science and Technology, Chiayi, Taiwan.
Huang TJ; Division of Thoracic Medicine, Chang Gung Memorial Hospital, Yunlin, Taiwan.
Chiu WN; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Yunlin, Taiwan.
Hu JH; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Yunlin, Taiwan.
Lin YC; Division of Family Medicine, Chang Gung Memorial Hospital, Yunlin, Taiwan.
Huang WC; Department of Geriatric, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Hsu NT; Biostatistics and Bioinformatics Center of Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Lu SN; Department of Internal Medicine, Division of Hepato-Gastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan; Biostatistics and Bioinformatics Center of Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2021 Feb; Vol. 120 (2), pp. 847-853. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Hepatitis B*/diagnosis
DNA, Viral ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Taiwan ; Viral Load
Czasopismo naukowe
Tytuł :
Hepatitis B virus reactivation during temozolomide administration for malignant glioma.
Autorzy :
Shoji T; Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Kanamori M; Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. .
Inoue J; Department of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Saito R; Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Osada Y; Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Shimoda Y; Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Chonan M; Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Uenohara H; Department of Neurosurgery, Sendai Medical Center, Sendai, Miyagi, Japan.
Masamune A; Department of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tominaga T; Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2021 Feb; Vol. 26 (2), pp. 305-315. Date of Electronic Publication: 2020 Oct 28.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms*/drug therapy
Brain Neoplasms*/virology
Glioma*/drug therapy
Glioma*/virology
Hepatitis B*/drug therapy
Hepatitis B virus*/drug effects
Hepatitis B virus*/immunology
Hepatitis B virus*/physiology
Temozolomide*/adverse effects
Temozolomide*/therapeutic use
Virus Activation*/drug effects
Antineoplastic Agents, Alkylating/adverse effects ; Antineoplastic Agents, Alkylating/therapeutic use ; DNA, Viral ; Hepatitis B Antibodies/immunology ; Humans ; Neoplasm Recurrence, Local ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma.
Autorzy :
Hara T; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Oka K; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Iwai N; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Inada Y; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Tsuji T; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Okuda T; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Nagata A; Department of Pathology, Fukuchiyama City Hospital, Japan.
Komaki T; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Kagawa K; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Feb 01; Vol. 60 (3), pp. 417-421. Date of Electronic Publication: 2020 Sep 19.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hepatitis B*
Peripheral Blood Stem Cell Transplantation*/adverse effects
Female ; Hepatitis B Surface Antigens ; Hepatitis B virus ; Humans ; Male ; Middle Aged ; Rituximab/adverse effects ; Virus Activation
Czasopismo naukowe
Tytuł :
[Risk analysis for hepatocellular carcinoma in patients with chronic hepatitis B-associated cirrhosis complicated by type 2 diabetes mellitus: a 5-year prospective cohort study].
Autorzy :
Tang C; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Hu C; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhou Y; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510310, China.
Song Y; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Li M; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Liao M; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Sun J; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhong C; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhou L; Department of Endocrinology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Lin Z; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhou Y; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Pokaż więcej
Źródło :
Nan fang yi ke da xue xue bao = Journal of Southern Medical University [Nan Fang Yi Ke Da Xue Xue Bao] 2021 Mar 25; Vol. 41 (3), pp. 313-318.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/etiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Adult ; Antiviral Agents/therapeutic use ; Hepatitis B virus ; Humans ; Liver Cirrhosis/complications ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/epidemiology ; Prospective Studies ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Tytuł :
Treatment eligibility in hepatitis B: a call for better linkage to optimal care.
Autorzy :
Huang DQ; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Gastroenterology and Hepatology, National University Health System, Singapore.
Nguyen MH; Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA; Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA 94304, USA. Electronic address: .
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2021 Mar; Vol. 6 (3), pp. 160.
Typ publikacji :
Letter; Comment
MeSH Terms :
Hepatitis B*/diagnosis
Hepatitis B*/drug therapy
Hepatitis B*/epidemiology
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Hepatitis B, Chronic*/prevention & control
Antiviral Agents/therapeutic use ; Hepatitis B Surface Antigens ; Humans
Opinia redakcyjna
Tytuł :
Extending treatment eligibility for chronic hepatitis B virus infection.
Autorzy :
McNaughton AL; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Lemoine M; Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Division of Digestive Diseases, Section of Hepatology and Gastroenterology, Imperial College, London, UK.
van Rensburg C; Division of Gastroenterology, Department of Medicine, Tygerberg Academic Hospital, Cape Town, South Africa.
Matthews PC; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK. .; Department of Microbiology and Infectious Diseases, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK. .
Pokaż więcej
Źródło :
Nature reviews. Gastroenterology & hepatology [Nat Rev Gastroenterol Hepatol] 2021 Mar; Vol. 18 (3), pp. 146-147.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Eligibility Determination*
Hepatitis B Vaccines*
Antiviral Agents/*therapeutic use
Hepatitis B, Chronic/*epidemiology
Hepatitis B, Chronic/*prevention & control
Hepatitis B, Chronic/transmission ; Humans
Czasopismo naukowe
Tytuł :
[Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
Autorzy :
Zeng YL; Department of Infectious Disease, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University People's Hospital, Zhengzhou 450003, China.
Gao F; Department of Infectious Disease, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University People's Hospital, Zhengzhou 450003, China.
Zhang C; Department of Infectious Disease, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University People's Hospital, Zhengzhou 450003, China.
Wei JF; Department of Infectious Disease, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University People's Hospital, Zhengzhou 450003, China.
Ma L; Department of Infectious Disease, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University People's Hospital, Zhengzhou 450003, China.
Ding GG; Department of Infectious Disease, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University People's Hospital, Zhengzhou 450003, China.
Li W; Department of Infectious Disease, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University People's Hospital, Zhengzhou 450003, China.
Shang J; Department of Infectious Disease, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University People's Hospital, Zhengzhou 450003, China.
Kang Y; Department of Infectious Disease, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University People's Hospital, Zhengzhou 450003, China.
Pokaż więcej
Źródło :
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 Feb 20; Vol. 29 (2), pp. 126-132.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B*
Hepatitis B virus*/genetics
DNA, Circular/genetics ; DNA, Viral/genetics ; Hep G2 Cells ; Hepatitis B Surface Antigens/genetics ; Humans ; RNA, Small Interfering/genetics ; Virus Replication
Czasopismo naukowe
Tytuł :
Editorial: HBV cure-the quest for biomarkers to predict off-treatment sustained response.
Autorzy :
Thibault V; Department of Virology, Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) UMR_S 1085, Rennes, France.
Asselah T; Department of Hepatology, CRI, INSERM, UMR 1149, AP-HP Hôpital Beaujon, Université de Paris, Clichy, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Feb; Vol. 53 (4), pp. 552-554.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Hepatitis B Surface Antigens*
Hepatitis B, Chronic*/diagnosis
Hepatitis B, Chronic*/drug therapy
Antigens, Viral ; Biomarkers ; Hepatitis B virus/genetics ; Humans ; Probability ; RNA
Opinia redakcyjna
Tytuł :
Chronic hepatitis B: identifying who needs to be treated and improving linkage to care.
Autorzy :
Spearman CW; Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa. Electronic address: .
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2021 Feb; Vol. 6 (2), pp. 83-85. Date of Electronic Publication: 2020 Nov 14.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Antiviral Agents*/therapeutic use
Hepatitis B*
Hepatitis B, Chronic*/diagnosis
Hepatitis B, Chronic*/drug therapy
Hepatitis B virus ; Humans
Czasopismo naukowe
Tytuł :
[Epidemiology and influencing factors of human immunodeficiency virus and hepatitis B virus co-infected patients in Beijing].
Autorzy :
Li Y; Department of Infectious Disease,Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100005, China.
Zhang L; Department of Infectious Disease,Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Xiao J; Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Jiang TY; Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Liu ZY; Department of Infectious Disease,Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Pokaż więcej
Źródło :
Zhonghua nei ke za zhi [Zhonghua Nei Ke Za Zhi] 2021 Mar 01; Vol. 60 (3), pp. 233-238.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-HIV Agents*/therapeutic use
Coinfection*/epidemiology
HIV Infections*/complications
HIV Infections*/epidemiology
Hepatitis B*/complications
Hepatitis B*/epidemiology
Adult ; HIV ; Hepatitis B virus ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' reply.
Autorzy :
Pol S; Université de Paris, Paris, France.; INSERM U-1223, Institut Pasteur, Paris, France.; Assistance Publique - Hôpitaux de Paris, Hôpital Cochin, Unité d'Hépatologie, Paris, France.
Luzivika Nzinga C; Sorbonne Université, Institut National de la santé et de la Recherche Médicale, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
Fontaine H; Assistance Publique - Hôpitaux de Paris, Hôpital Cochin, Unité d'Hépatologie, Paris, France.
Carrat F; Sorbonne Université, Institut National de la santé et de la Recherche Médicale, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.; Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France.
Pokaż więcej
Corporate Authors :
French ANRS CO22 Hepather cohort
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Mar; Vol. 53 (5), pp. 659.
Typ publikacji :
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/epidemiology
Antiviral Agents/adverse effects ; Europe/epidemiology ; Guanine/analogs & derivatives ; Hepatitis B virus ; Humans ; Tenofovir/adverse effects
Raport
Tytuł :
Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort.
Autorzy :
Pol S; Assistance Publique - Hôpitaux de Paris, Hôpital Cochin, Unité d'Hépatologie, Paris, France.; Université Paris Descartes, INSERM U-1223, Institut Pasteur, Paris, France.
Pokaż więcej
Corporate Authors :
ANRS/AFEF study group
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Mar; Vol. 53 (5), pp. 616-629. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Liver Neoplasms*/drug therapy
Liver Neoplasms*/epidemiology
Antiviral Agents/adverse effects ; Guanine/analogs & derivatives ; Hepatitis B virus ; Humans ; Prospective Studies ; Tenofovir/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[Safety and immunogenicity analysis of recombinant (hansenula polymorpha) hepatitis B vaccine (CpG ODN adjuvant) among adults: the preliminary results of phase I clinical trial].
Autorzy :
Liang ZZ; Institute for Immunization and Prevention, Zhejiang Provincial Center of Disease Control and Prevention, Hangzhou 310051, China.
Shao Y; Changchun Huapu Bio-Tech Co., Ltd, Changchun 130103, China.
Wang SY; Institute for Immunization and Prevention, Zhejiang Provincial Center of Disease Control and Prevention, Hangzhou 310051, China.
Yan CF; Kaihua Center of Disease Control and Prevention, Quzhou 324300, Zhejiang Province, China.
Chen B; Kaihua Center of Disease Control and Prevention, Quzhou 324300, Zhejiang Province, China.
Zhang J; Changchun Huapu Bio-Tech Co., Ltd, Changchun 130103, China.
Chen YP; Institute for Immunization and Prevention, Zhejiang Provincial Center of Disease Control and Prevention, Hangzhou 310051, China.
Hu XS; Institute for Immunization and Prevention, Zhejiang Provincial Center of Disease Control and Prevention, Hangzhou 310051, China.
Lyu HK; Institute for Immunization and Prevention, Zhejiang Provincial Center of Disease Control and Prevention, Hangzhou 310051, China.
Pokaż więcej
Źródło :
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] [Zhonghua Yu Fang Yi Xue Za Zhi] 2020 Aug 06; Vol. 54 (8), pp. 854-860.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
MeSH Terms :
Hepatitis B Vaccines*
Hepatitis B/*prevention & control
Adolescent ; Adult ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Humans ; Middle Aged ; Pichia ; Young Adult
Czasopismo naukowe
Tytuł :
Editorial: similar risk of hepatocellar carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe.
Autorzy :
Lampertico P; Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy.; Department of Pathophysiology and Transplantation, CRC 'A. M. and A. Migliavacca' Center for Liver Disease, University of Milan, Milan, Italy.
Papatheodoridis GV; Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens 'Laiko', Athens, Greece.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Mar; Vol. 53 (5), pp. 657-658.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/epidemiology
Antiviral Agents/adverse effects ; Europe ; Guanine/analogs & derivatives ; Hepatitis B virus ; Humans ; Tenofovir/adverse effects
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies